Award
Delivery Order #SPE2D326F6770
Delivery Order for Ondansetron Tablets to Support Military Medical Needs
Buyer
Defense Logistics Agency
Award Amount
$17,065.50
Ceiling
$17,065.50
Awarded
February 27, 2026
Period of Performance
Feb 27, 2026 – Mar 02, 2026
Identifier
SPE2D326F6770
NAICS
325411
This award represents a delivery order contract issued under an existing indefinite delivery contract with Chartwell RX LLC, a pharmaceutical manufacturer and distributor specializing in essential military medications. The specific procurement involves ondansetron ODT 8 mg tablets, a critical anti-nausea medication used in military healthcare settings. This delivery order supports the larger goal of enhancing the U.S. military's medical readiness by ensuring timely access to necessary pharmaceutical products. The contract work includes the delivery of the specified tablets to a designated military facility in Congers, NY, within a short, fixed timeframe. The order was placed as part of a long-term, sole-source agreement reflecting the urgency and reliable supply chain needs for critical medicines. This recent delivery order continues the ongoing commitment to maintain a consistent supply of vital pharmaceuticals for military healthcare operations, underpinning the agency's capability to meet emergent medical requirements effectively.
Description
4570977424!ONDANSETRON ODT 8 MG TABLET 30S